NuCana plc American Depositary Share

Go to NuCana plc American Depositary Share Website

$0.04

0.00 (0.00%)
Live
Previous Close

$0.0425

Day Range

$0 - $0

Previous Day Range

$0.0411 - $0.05

Market Cap

$17.4 million USD

Day Vol.

0

Previous Day Vol.

91.1 million

Currency

USD

Primary Exchange

Nasdaq

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mec...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

NuCana reported a net loss of £7.0 million for Q2 2024 and had £11.6 million in cash as of June 30, 2024. The company is advancing its clinical programs, including NUC-3373 and NUC-7738, and expects to announce data readouts in the second half of 2024.

Related tickers: NCNA.

Read Full Article

NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at the Jefferies Global Healthcare Conference.

Related tickers: NCNA.

Read Full Article
Trending Tickers

Please sign in to view